Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Price:
1 814.6
INR
0.32%
Market Closed
Market Cap:
4.4T
INR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
SUNPHARMA Alert
Sun Pharmaceutical Industries Ltd
1814.6
+5.75 (+0.32%)
| 52 Week Range |
1 247.5
1 948.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Sun Pharmaceutical Industries Ltd
Income Statement
Earnings Waterfall
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
|
Revenue
|
503.1B
INR
|
|
Cost of Revenue
|
-104.9B
INR
|
|
Gross Profit
|
398.2B
INR
|
|
Operating Expenses
|
-285.7B
INR
|
|
Operating Income
|
112.5B
INR
|
|
Other Expenses
|
-1.9B
INR
|
|
Net Income
|
110.5B
INR
|
Income Statement
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Currency: INR
| Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
227 546
N/A
|
253 746
+12%
|
273 920
+8%
|
278 094
+2%
|
266 433
-4%
|
268 332
+1%
|
284 870
+6%
|
299 819
+5%
|
313 687
+5%
|
321 715
+3%
|
315 784
-2%
|
295 666
-6%
|
279 568
-5%
|
266 849
-5%
|
264 895
-1%
|
275 048
+4%
|
277 921
+1%
|
288 791
+4%
|
290 659
+1%
|
302 161
+4%
|
314 019
+4%
|
318 166
+1%
|
328 375
+3%
|
320 485
-2%
|
324 782
+1%
|
331 601
+2%
|
334 981
+1%
|
356 316
+6%
|
367 045
+3%
|
377 307
+3%
|
386 545
+2%
|
396 975
+3%
|
410 239
+3%
|
424 018
+3%
|
438 857
+3%
|
450 648
+3%
|
463 049
+3%
|
474 446
+2%
|
484 969
+2%
|
492 088
+1%
|
503 077
+2%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(49 160)
|
(58 462)
|
(77 759)
|
(67 852)
|
(64 658)
|
(64 859)
|
(77 129)
|
(64 862)
|
(68 283)
|
(73 442)
|
(96 950)
|
(79 612)
|
(79 988)
|
(78 498)
|
(88 997)
|
(78 541)
|
(77 343)
|
(78 003)
|
(92 388)
|
(82 200)
|
(87 302)
|
(87 645)
|
(104 713)
|
(87 423)
|
(86 207)
|
(87 541)
|
(98 854)
|
(93 699)
|
(97 455)
|
(100 527)
|
(117 077)
|
(106 023)
|
(107 885)
|
(109 516)
|
(119 424)
|
(105 201)
|
(105 992)
|
(105 324)
|
(120 697)
|
(105 799)
|
(104 870)
|
|
| Gross Profit |
178 388
N/A
|
195 285
+9%
|
196 161
+0%
|
210 242
+7%
|
201 775
-4%
|
203 473
+1%
|
207 742
+2%
|
234 956
+13%
|
245 404
+4%
|
248 274
+1%
|
218 834
-12%
|
216 055
-1%
|
199 580
-8%
|
188 350
-6%
|
175 898
-7%
|
196 506
+12%
|
200 577
+2%
|
210 787
+5%
|
198 272
-6%
|
219 961
+11%
|
226 717
+3%
|
230 521
+2%
|
223 662
-3%
|
233 062
+4%
|
238 575
+2%
|
244 060
+2%
|
236 127
-3%
|
262 617
+11%
|
269 590
+3%
|
276 780
+3%
|
269 468
-3%
|
290 952
+8%
|
302 353
+4%
|
314 502
+4%
|
319 433
+2%
|
345 446
+8%
|
357 057
+3%
|
369 122
+3%
|
364 272
-1%
|
386 289
+6%
|
398 208
+3%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(99 421)
|
(115 917)
|
(126 811)
|
(145 273)
|
(148 632)
|
(149 744)
|
(131 474)
|
(152 975)
|
(150 929)
|
(152 282)
|
(132 563)
|
(146 370)
|
(148 365)
|
(147 459)
|
(133 261)
|
(150 865)
|
(151 403)
|
(155 935)
|
(149 237)
|
(169 103)
|
(176 481)
|
(184 976)
|
(173 366)
|
(185 875)
|
(186 358)
|
(185 944)
|
(171 591)
|
(189 044)
|
(192 368)
|
(196 952)
|
(187 989)
|
(210 824)
|
(218 104)
|
(266 774)
|
(226 625)
|
(247 735)
|
(259 420)
|
(267 652)
|
(259 175)
|
(278 172)
|
(285 747)
|
|
| Selling, General & Administrative |
(32 511)
|
(38 398)
|
(105 659)
|
(46 037)
|
(47 018)
|
(47 344)
|
(111 231)
|
(47 764)
|
(47 631)
|
(48 405)
|
(110 367)
|
(49 929)
|
(51 171)
|
(52 746)
|
(111 254)
|
(54 702)
|
(56 172)
|
(57 396)
|
(124 294)
|
(60 745)
|
(62 251)
|
(62 792)
|
(145 939)
|
(65 809)
|
(66 653)
|
(68 367)
|
(143 448)
|
(68 620)
|
(69 630)
|
(70 934)
|
(159 454)
|
(76 169)
|
(78 152)
|
(80 014)
|
(193 949)
|
(86 232)
|
(89 830)
|
(93 093)
|
(221 717)
|
(95 430)
|
(96 564)
|
|
| Depreciation & Amortization |
(7 155)
|
(8 389)
|
(11 947)
|
(11 995)
|
(11 888)
|
(12 113)
|
(10 375)
|
(11 133)
|
(11 587)
|
(12 146)
|
(12 648)
|
(12 954)
|
(13 503)
|
(13 828)
|
(14 998)
|
(15 548)
|
(16 226)
|
(17 544)
|
(17 533)
|
(18 088)
|
(18 556)
|
(19 315)
|
(20 528)
|
(20 916)
|
(21 169)
|
(21 018)
|
(20 800)
|
(20 872)
|
(21 190)
|
(21 408)
|
(21 437)
|
(22 285)
|
(23 081)
|
(24 144)
|
(25 294)
|
(25 928)
|
(26 156)
|
(25 778)
|
(25 568)
|
(25 605)
|
(25 535)
|
|
| Other Operating Expenses |
(59 757)
|
(69 131)
|
(9 205)
|
(87 241)
|
(89 726)
|
(90 287)
|
(9 868)
|
(94 079)
|
(91 711)
|
(91 731)
|
(9 548)
|
(83 486)
|
(83 691)
|
(80 884)
|
(7 009)
|
(80 613)
|
(79 003)
|
(80 995)
|
(7 411)
|
(90 271)
|
(95 675)
|
(102 869)
|
(6 899)
|
(99 149)
|
(98 535)
|
(96 558)
|
(7 344)
|
(99 552)
|
(101 548)
|
(104 610)
|
(7 097)
|
(112 370)
|
(116 871)
|
(162 616)
|
(7 382)
|
(135 575)
|
(143 434)
|
(148 782)
|
(11 890)
|
(157 137)
|
(163 648)
|
|
| Operating Income |
78 965
N/A
|
79 367
+1%
|
69 351
-13%
|
64 970
-6%
|
53 144
-18%
|
53 731
+1%
|
76 267
+42%
|
81 982
+7%
|
94 476
+15%
|
95 991
+2%
|
86 272
-10%
|
69 685
-19%
|
51 216
-27%
|
40 894
-20%
|
42 637
+4%
|
45 645
+7%
|
49 178
+8%
|
54 855
+12%
|
49 034
-11%
|
50 859
+4%
|
50 236
-1%
|
45 544
-9%
|
50 296
+10%
|
47 187
-6%
|
52 217
+11%
|
58 117
+11%
|
64 536
+11%
|
73 573
+14%
|
77 222
+5%
|
79 829
+3%
|
81 479
+2%
|
80 128
-2%
|
84 249
+5%
|
47 728
-43%
|
92 807
+94%
|
97 712
+5%
|
97 637
0%
|
101 470
+4%
|
105 097
+4%
|
108 117
+3%
|
112 460
+4%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(3 212)
|
(4 642)
|
(2 049)
|
(5 809)
|
(5 774)
|
(5 553)
|
(3 544)
|
(5 234)
|
(4 189)
|
(4 578)
|
4 324
|
(3 746)
|
(4 783)
|
(4 071)
|
569
|
(5 390)
|
(7 767)
|
(8 262)
|
478
|
(7 266)
|
(4 069)
|
(2 433)
|
1 237
|
(2 233)
|
(2 975)
|
(2 708)
|
5 863
|
(1 002)
|
(629)
|
(1 380)
|
5 347
|
1 138
|
(348)
|
(545)
|
2 812
|
(5 089)
|
(3 314)
|
(1 923)
|
12 266
|
(1 331)
|
92
|
|
| Non-Reccuring Items |
(2 378)
|
(2 378)
|
(3 542)
|
(6 852)
|
(6 852)
|
(6 852)
|
(7 530)
|
0
|
0
|
0
|
(9)
|
(9 505)
|
(9 505)
|
(9 505)
|
(8 806)
|
0
|
(12 144)
|
(12 144)
|
(12 157)
|
(12 144)
|
0
|
0
|
(2 608)
|
(38 939)
|
(38 939)
|
(38 939)
|
(43 070)
|
(13 039)
|
(13 039)
|
(13 039)
|
(45 703)
|
(39 358)
|
(39 358)
|
0
|
(1 884)
|
(4 943)
|
(4 943)
|
(5 641)
|
(4 927)
|
(1 700)
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
(268)
|
0
|
0
|
0
|
436
|
0
|
0
|
0
|
(109)
|
0
|
0
|
0
|
(202)
|
0
|
0
|
0
|
(666)
|
0
|
0
|
0
|
(52)
|
0
|
0
|
0
|
139
|
0
|
0
|
0
|
348
|
0
|
0
|
0
|
75
|
0
|
0
|
0
|
(100)
|
0
|
0
|
|
| Total Other Income |
5 234
|
3 125
|
537
|
5 462
|
6 923
|
9 417
|
77
|
6 512
|
6 554
|
6 047
|
1
|
6 181
|
7 535
|
7 605
|
592
|
8 863
|
9 826
|
10 466
|
1 413
|
10 388
|
8 885
|
8 153
|
1 223
|
5 768
|
6 317
|
8 268
|
526
|
8 343
|
8 014
|
9 189
|
3 342
|
7 711
|
6 335
|
3 748
|
273
|
8 368
|
10 452
|
11 215
|
(1 457)
|
15 216
|
15 820
|
|
| Pre-Tax Income |
78 608
N/A
|
75 471
-4%
|
64 029
-15%
|
57 771
-10%
|
47 442
-18%
|
50 744
+7%
|
65 706
+29%
|
83 261
+27%
|
96 840
+16%
|
97 459
+1%
|
90 479
-7%
|
62 614
-31%
|
44 463
-29%
|
34 922
-21%
|
34 790
0%
|
49 118
+41%
|
39 093
-20%
|
44 915
+15%
|
38 102
-15%
|
41 836
+10%
|
55 051
+32%
|
51 263
-7%
|
50 096
-2%
|
11 782
-76%
|
16 620
+41%
|
24 738
+49%
|
27 994
+13%
|
67 876
+142%
|
71 569
+5%
|
74 600
+4%
|
44 813
-40%
|
49 619
+11%
|
50 879
+3%
|
50 931
+0%
|
94 084
+85%
|
96 047
+2%
|
99 832
+4%
|
105 121
+5%
|
110 879
+5%
|
120 303
+8%
|
128 373
+7%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(7 608)
|
(15 460)
|
(9 147)
|
(8 213)
|
(8 365)
|
1 037
|
(9 138)
|
(11 537)
|
(13 008)
|
(15 849)
|
(12 116)
|
(10 207)
|
(7 460)
|
(6 526)
|
(6 566)
|
(5 839)
|
(6 866)
|
(6 780)
|
(6 009)
|
(6 579)
|
(6 542)
|
(7 109)
|
(8 228)
|
(9 226)
|
(6 254)
|
(5 427)
|
(5 147)
|
(6 643)
|
(8 933)
|
(9 838)
|
(10 755)
|
(8 689)
|
(8 234)
|
(7 714)
|
(8 476)
|
(11 267)
|
(13 645)
|
(15 134)
|
(14 395)
|
(15 236)
|
(17 007)
|
|
| Income from Continuing Operations |
71 001
|
60 013
|
54 882
|
49 560
|
39 077
|
51 780
|
56 569
|
71 723
|
83 833
|
81 611
|
78 363
|
52 408
|
37 003
|
28 396
|
28 224
|
43 279
|
32 227
|
38 135
|
32 093
|
35 259
|
48 511
|
44 156
|
41 868
|
2 557
|
10 367
|
19 311
|
22 847
|
61 232
|
62 635
|
64 762
|
34 058
|
40 930
|
42 645
|
43 217
|
85 608
|
84 780
|
86 186
|
89 986
|
96 484
|
105 067
|
111 365
|
|
| Income to Minority Interest |
(7 852)
|
(8 165)
|
(9 363)
|
(10 521)
|
(10 483)
|
(11 631)
|
(11 126)
|
(11 459)
|
(11 115)
|
(9 667)
|
(8 819)
|
(7 502)
|
(6 039)
|
(3 887)
|
(4 468)
|
(4 731)
|
(4 934)
|
(6 778)
|
(5 424)
|
(5 231)
|
(5 122)
|
(3 989)
|
(4 070)
|
4 727
|
4 418
|
4 868
|
6 315
|
(990)
|
(84)
|
(149)
|
(1 166)
|
(1 892)
|
(1 435)
|
(908)
|
(394)
|
100
|
(59)
|
(279)
|
(337)
|
(754)
|
(630)
|
|
| Equity Earnings Affiliates |
(30)
|
(86)
|
(126)
|
(131)
|
100
|
40
|
15
|
(29)
|
(420)
|
(376)
|
99
|
151
|
307
|
389
|
(254)
|
(225)
|
(232)
|
(224)
|
(15)
|
(72)
|
(95)
|
(156)
|
(148)
|
(65)
|
(79)
|
(83)
|
(123)
|
(205)
|
(173)
|
(171)
|
(165)
|
(144)
|
(163)
|
(190)
|
(479)
|
(528)
|
(642)
|
(644)
|
(384)
|
(418)
|
(194)
|
|
| Net Income (Common) |
63 101
N/A
|
51 743
-18%
|
45 394
-12%
|
38 906
-14%
|
28 692
-26%
|
40 188
+40%
|
45 457
+13%
|
60 235
+33%
|
72 298
+20%
|
71 567
-1%
|
69 644
-3%
|
45 057
-35%
|
31 272
-31%
|
19 770
-37%
|
20 957
+6%
|
35 780
+71%
|
24 518
-31%
|
33 721
+38%
|
26 654
-21%
|
29 957
+12%
|
43 294
+45%
|
40 010
-8%
|
37 649
-6%
|
7 218
-81%
|
14 705
+104%
|
24 095
+64%
|
29 038
+21%
|
60 036
+107%
|
62 378
+4%
|
64 441
+3%
|
32 727
-49%
|
38 894
+19%
|
41 047
+6%
|
42 119
+3%
|
84 736
+101%
|
84 352
0%
|
85 485
+1%
|
89 063
+4%
|
95 764
+8%
|
103 895
+8%
|
110 541
+6%
|
|
| EPS (Diluted) |
30.46
N/A
|
25
-18%
|
18.87
-25%
|
16.27
-14%
|
11.98
-26%
|
16.69
+39%
|
18.88
+13%
|
25.01
+32%
|
30.08
+20%
|
29.83
-1%
|
28.98
-3%
|
19.08
-34%
|
12.69
-33%
|
8.23
-35%
|
8.73
+6%
|
14.92
+71%
|
10.08
-32%
|
14.06
+39%
|
11.11
-21%
|
12.48
+12%
|
18.04
+45%
|
16.67
-8%
|
15.69
-6%
|
3
-81%
|
6.13
+104%
|
10.04
+64%
|
12.1
+21%
|
24.94
+106%
|
25.9
+4%
|
26.91
+4%
|
13.64
-49%
|
16.23
+19%
|
17.07
+5%
|
17.5
+3%
|
35.32
+102%
|
35.03
-1%
|
35.61
+2%
|
37.05
+4%
|
39.91
+8%
|
43.23
+8%
|
46.17
+7%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
